Drug Development
Hyundai Bioscience to conduct antiviral trials for Dengue in Brazil
The Niclosamide-based antiviral is intended for treating Dengue and other mosquito-borne viruses.
Actinogen finishes enrolling patients in depression therapy trial
Lantern Pharma cleared to expand lung cancer treatment trial
D2M Biotherapeutics doses first subject in solid tumour treatment trial
Philippine FDA grants clearance for YS Biopharma’s hepatitis B vaccine trial
AbbVie reports findings from giant cell arteritis therapy trial
